Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2006-09-12
Original market date: See footnote 1
1995-12-31
Product name:
SALOFALK (R) 5-ASA SUPPOSITORIES - 250MG
Description:
ALSO KNOWN AS MESALAMINE
DIN:
02112752
Product Monograph/Veterinary Labelling:
Date:
2004-09-10
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
AXCAN PHARMA INC
597 Laurier Blvd
Mont St-Hilaire
Quebec
Canada
J3H 6C4
Class:
Human
Dosage form(s):
Suppository
Route(s) of administration:
Rectal
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
56:36.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A07EC02 MESALAZINE
Active ingredient group (AIG) number:See footnote5
0116808003
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| MESALAZINE | 250 MG |